Knowing that cells can leave the primary tumor and being able to circulate in the blood system, Prof. Dr. med. Katharina Pachmann developed the maintrac system. More than 80.000 samples were already analyzed and more than 950 patients in 16 clinical trials profed the system. By labeling the epithelial cells with anitobdies and detecting them by fluorescence dispensing any fixation, isolation. or enrichment, maintrac is able to detect almost all circulating tumor cells in a patients blood sample. maintrac is a prognostic and predictive marker for personalized therapeutic decisions.
AutomationCancer ResearchDrug DiscoveryInformatics